-+ 0.00%
-+ 0.00%
-+ 0.00%

OS Therapies Intends To Spin Off OS Animal Health Into Standalone Public Entity

Benzinga·11/20/2025 12:46:07
Listen to the news

OS Therapies Inc. (NYSE:OSTX) ("OS Therapies" or "the Company"), the world leader in listeria-based cancer immunotherapies, today announced its intent to spin off OS Animal Health, Inc. (OSAH) into a standalone public company listed on a national stock exchange. OSAH is the Company's wholly owned subsidiary developing OST-HER2 for canine osteosarcoma. The Company expects OSAH to become a standalone public company on a U.S. national stock exchange in the first half of 2026.